You are here: Industry Insights > AZ

News List

AZ and Pieris link in $2.1bn respiratory deal pharmatimes
May 05, 2017
AstraZeneca has hooked up with US group Pieris Pharmaceuticals to develop novel inhaled medicines for respiratory...
AZ’ Imfinzi gets accelerated nod for bladder cancer pharmatimes
May 04, 2017
AstraZeneca has secured accelerated approval in the US for its immunotherapy Imfinzi as a treatment for certain patients with advanced bladder cancer.
Mixed first quarter fortunes for GSK, AZ pharmatimes
April 28, 2017
GlaxoSmithKline saw its first-quarter sales leap nearly 20 percent as growth across all of its key businesses was given a significant helping hand by currency effects.
AZ's Tagrisso continues successes with EU approval pharmafile
April 27, 2017
More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission...
AstraZeneca Announces ‘Topping Out’ of Global R&D Center and HQ in Cambridge, UK americanpharmaceuticalreview
April 26, 2017
AstraZeneca announced the ‘topping out’ of its new R&D center and global corporate headquarters at the Cambridge Biomedical Campus (CBC).
Tagrisso (osimertinib) Receives FDA Full Approval drugs.com
April 06, 2017
AstraZeneca announced that the US Food and Drug Administration (FDA) has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets...
GSK snatches AZ Europe VP to replace exiting global head of pharma pharmafile
January 20, 2017
GlaxoSmithKline has announced that its global head of pharmaceuticals Abbas Hussain (pictured) is leaving the company; the vacated role will then be filled by AstraZeneca’s vice president of European business Luke Miels.

Previous page 1 2 3 4 5 Next page